A Study to Assess the Relative Bioavailability of 3 Different Formulations Under Fasted and Fed Condition

Clinical trial NCT04024501 · COMPLETED

Trial details

NCT number: NCT04024501
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Kidney Disease

Start date: 2019-07-20
Primary completion: 2019-09-18
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.